Broad activation of the Parkin pathway induces synaptic mitochondrial deficits in early tauopathy
Authors:
Open Access
- 12 January 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in Brain
- Vol. 145 (1) , 305-323
Abstract
Mitochondrial defects are a hallmark of early pathophysiology in Alzheimer’s disease, with pathologically phosphorylated tau reported to induce mitochondrial toxicity. Mitophagy constitutes a key pathway in mitochondrial quality control by which damaged mitochondria are targeted for autophagy. However, few details are known regarding the intersection of mitophagy and pathologies in tauopathy. Here, by applying biochemical and cell biological approaches including time-lapse confocal imaging in live tauopathy neurons, combined with gene rescue experiments via stereotactic injections of adeno-associated virus particles into tauopathy mouse brains, electrophysiological recordings and behavioural tests, we demonstrate for the first time that mitochondrial distribution deficits at presynaptic terminals are an early pathological feature in tauopathy brains. Furthermore, Parkin-mediated mitophagy is extensively activated in tauopathy neurons, which accelerates mitochondrial Rho GTPase 1 (Miro1) turnover and consequently halts Miro1-mediated mitochondrial anterograde movement towards synaptic terminals. As a result, mitochondrial supply at tauopathy synapses is disrupted, impairing synaptic function. Strikingly, increasing Miro1 levels restores the synaptic mitochondrial population by enhancing mitochondrial anterograde movement and thus reverses tauopathy-associated synaptic failure. In tauopathy mouse brains, overexpression of Miro1 markedly elevates synaptic distribution of mitochondria and protects against synaptic damage and neurodegeneration, thereby counteracting impairments in learning and memory as well as synaptic plasticity. Taken together, our study reveals that activation of the Parkin pathway triggers an unexpected effect—depletion of mitochondria from synaptic terminals, a characteristic feature of early tauopathy. We further provide new mechanistic insights into how parkin activation-enhanced Miro1 degradation and impaired mitochondrial anterograde transport drive tauopathy-linked synaptic pathogenesis and establish a foundation for future investigations into new therapeutic strategies to prevent synaptic deterioration in Alzheimer’s disease and other tauopathies.Keywords
Funding Information
- National Institutes of Health (R01NS089737, R01GM135326, R21NS102780 (to Q.C.), R21HD091512, R01NS102382 (to P.J.), R01DC015000 (to K.K.), R01NS089737, NSF IOS-1845355 (to D.J.M.))
This publication has 101 references indexed in Scilit:
- Spatial Parkin Translocation and Degradation of Damaged Mitochondria via Mitophagy in Live Cortical NeuronsCurrent Biology, 2012
- PINK1 and Parkin Target Miro for Phosphorylation and Degradation to Arrest Mitochondrial MotilityCell, 2011
- Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer's diseaseBrain Research, 2011
- Tau Mislocalization to Dendritic Spines Mediates Synaptic Dysfunction Independently of NeurodegenerationNeuron, 2010
- Snapin-Regulated Late Endosomal Transport Is Critical for Efficient Autophagy-Lysosomal Function in NeuronsNeuron, 2010
- Structural and functional changes in tau mutant mice neurons are not linked to the presence of NFTsExperimental Neurology, 2010
- Up-regulation of calcyon results in locomotor hyperactivity and reduced anxiety in miceBehavioural Brain Research, 2008
- The mitochondrial impairment, oxidative stress and neurodegeneration connection: reality or just an attractive hypothesis?Trends in Neurosciences, 2008
- Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's diseaseTrends in Molecular Medicine, 2008
- Docking of Axonal Mitochondria by Syntaphilin Controls Their Mobility and Affects Short-Term FacilitationCell, 2008